Differential expression of connective tissue growth factor and extracellular matrix proteins in lichen sclerosus

Journal of the European Academy of Dermatology and Venereology

Volumn 26, Issue 2, 2012, Pages 207-212

  Gambichler, T ^a   Skrygan, M ^a   Czempiel, V ^a   Tigges, C ^a   Kobus, S ^a   Meier, J J ^a   Kohler C U ^a   Scola, N ^a   Stucker M ^a   Altmeyer, P ^a   Kreuter, A ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIGLYCAN; CONNECTIVE TISSUE GROWTH FACTOR; DECORIN; FIBRONECTIN; INTERSTITIAL COLLAGENASE; PERLECAN; SCLEROPROTEIN; SMAD3 PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1; VERSICAN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LICHEN SCLEROSUS ET ATROPHICUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; CONNECTIVE TISSUE GROWTH FACTOR; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LICHEN SCLEROSUS ET ATROPHICUS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84856337940     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2011.04037.x     Document Type: Article

References (30)

1. Powell JJ, Wojnarowska F,. Lichen sclerosus. Lancet 1999; 353: 1777-1783. (Pubitemid 29240387)
2. Powell JJ, Wojnarowska F, Winsey S, Marren P, Welsh K,. Lichen sclerosus premenarche: autoimmunity and immunogenetics. Br J Dermatol 2000; 142: 481-484. (Pubitemid 30159071)
3. Gambichler T, Skrygan M, Tigges C, Kobus S, Gläser R, Kreuter A,. Significant upregulation of antimicrobial peptides and proteins in lichen sclerosus. Br J Dermatol 2009; 161: 1136-1142.
4. Funaro D,. Lichen sclerosus: a review and practical approach. Dermatol Ther 2004; 17: 28-37.
5. Oyama N, Chan I, Neill SM, et al. Autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Lancet 2003; 362: 118-123. (Pubitemid 36831022)
6. Nowinski D, Koskela A, Kiwanuka E, Boström M, Gerdin B, Ivarsson M,. Inhibition of connective tissue growth factor/CCN2 expression in human dermal fibroblasts by interleukin-1alpha and beta. J Cell Biochem 2010; 110: 1226-1233.
7. Leask A,. Targeting the TGFbeta, endothelin-1 and CCN2 axis to combat fibrosis in scleroderma. Cell Signal 2008; 20: 1409-1414.
8. Iozzo RV,. Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 1998; 67: 609-652. (Pubitemid 28411140)
9. Kolácná L, Bakesová J, Varga F, et al. Biochemical and biophysical aspects of collagen nanostructure in the extracellular matrix. Physiol Res 2007; 56 (Suppl. 1): 51-60.
10. Toriseva M, Kähäri VM,. Proteinases in cutaneous wound healing. Cell Mol Life Sci 2009; 66: 203-224.
11. Tran KT, Griffith L, Wells A,. Extracellular matrix signaling through growth factor receptors during wound healing. Wound Repair Regen 2004; 12: 262-268. (Pubitemid 38880434)
12. Kuroda K, Fujimoto N, Tajima S,. Abnormal accumulation of inter-alpha-trypsin inhibitor and hyaluronic acid in lichen sclerosus. J Cutan Pathol 2005; 32: 137-140. (Pubitemid 40216050)
13. Farrell AM, Dean D, Millard PR, Charnock FM, Wojnarowska F,. Alterations in fibrillin as well as collagens I and III and elastin occur in vulval lichen sclerosus. J Eur Acad Dermatol Venereol 2001; 15: 212-217. (Pubitemid 32898862)
14. Frances C, Wechsler J, Meimon G, Labat-Robert J, Grimaud JA, Hewitt J,. Investigation of intercellular matrix macromolecules involved in lichen sclerosus. Acta Derm Venereol 1983; 63: 483-490. (Pubitemid 14208360)
15. Oikarinen A, Sandberg M, Hurskainen T, Kinnunen T, Kallioinen M,. Collagen biosynthesis in lichen sclerosus et atrophicus studied by biochemical and in situ hybridization techniques. Acta Derm Venereol Suppl (Stockh) 1991; 162: 3-12.
16. Farrell AM, Dean D, Charnock FM, Wojnarowska F,. Alterations in distribution of tenascin, fibronectin and fibrinogen in vulval lichen sclerosus. Dermatology 2000; 201: 223-229.
17. Farrell AM, Dean D, Charnock M, Wojnarowska F,. Distribution of transforming growth factor-beta isoforms TGF-beta 1, TGF-beta 2 and TGF-beta 3 and vascular endothelial growth factor in vulvar lichen sclerosus. J Reprod Med 2001; 46: 117-124. (Pubitemid 32205254)
18. Corrêa AC, Azevedo L, Almeida G, do Val I, Cuzzi T, Takiya CM,. Decorin and chondroitin sulfate distribution in vulvar lichen sclerosus: correlation with distinct histopathologic stages. J Reprod Med 2007; 52: 38-42. (Pubitemid 46980025)
19. Carli P, Moretti S, Spallanzani A, Berti E, Cattaneo A,. Fibrogenic cytokines in vulvar lichen sclerosus. An immunohistochemical study. J Reprod Med 1997; 42: 161-165. (Pubitemid 27164438)
20. Soini Y, Pöllänen R, Autio-Harmainen H, Lehto VP,. Tenascin expression in lichen sclerosus. Int J Gynecol Pathol 1997; 16: 313-318. (Pubitemid 27413520)
21. Livak KJ, Schmittgen TD,. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408. (Pubitemid 34164012)
22. Gambichler T, Birkner L, Stücker M, Othlinghaus N, Altmeyer P, Kreuter A,. Up-regulation of transforming growth factor-beta3 and extracellular matrix proteins in acquired reactive perforating collagenosis. J Am Acad Dermatol 2009; 60: 463-469.
23. Verrecchia F, Mauviel A,. Transforming growth factor-beta and fibrosis. World J Gastroenterol 2007; 13: 3056-3062.
24. Sgonc R, Wick G,. Pro- and anti-fibrotic effects of TGF-beta in scleroderma. Rheumatology (Oxford) 2008; 47 (Suppl. 5): v5-v7.
25. Abraham D,. Connective tissue growth factor: growth factor, matricellular organizer, fibrotic biomarker or molecular target for anti-fibrotic therapy in SSc? Rheumatology (Oxford) 2008; 47 (Suppl. 5): v8-v9.
26. Leask A, Abraham DJ,. TGF-beta signaling and the fibrotic response. FASEB J 2004; 18: 816-827.
27. Holmes A, Abraham DJ, Sa S, Shiwen X, Black CM, Leask A,. CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J Biol Chem 2001; 276: 10594-10601. (Pubitemid 38089227)
28. Chan I,. The role of extracellular matrix protein 1 in human skin. Clin Exp Dermatol 2004; 29: 52-55.
29. Chan I, Oyama N, Neill SM, Wojnarowska F, Black MM, McGrath JA,. Characterization of IgG autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Clin Exp Dermatol 2004; 29: 499-504. (Pubitemid 39278197)
30. Kowalewski C, Kozłowska A, Chan I, et al. Three-dimensional imaging reveals major changes in skin microvasculature in lipoid proteinosis and lichen sclerosus. J Dermatol Sci 2005; 38: 215-224. (Pubitemid 40779575)